CoChat

Alzheimer’s disease CSF biomarkers: clinical indications and rational use

Open access
Niemantsverdriet, Ellis, Valckx, Sara, Bjerke, Maria, Engelborghs, Sebastiaan · 2017 · Acta Neurologica Belgica
Cited by 114

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Abstract

This review focusses on the validation and standardization of Alzheimer’s disease (AD) cerebrospinal fluid (CSF) biomarkers, as well as on the current clinical indications and rational use of CSF biomarkers in daily clinical practice. The validated AD CSF biomarkers, Aβ 1-42 , T-tau, and P-tau 181 , have an added value in the (differential) diagnosis of AD and related disorders, including mixed pathologies, atypical presentations, and in case of ambiguous clinical dementia diagnosis. CSF biomarkers should not be routinely used in the diagnostic work-up of dementia and cannot be used to diagnose non-AD dementias. In cognitively healthy subjects, CSF biomarkers can only be applied for research purposes, e.g., to identify pre-clinical AD in the context of clinical trials with potentially disease-modifying drugs. Therefore, biomarker-based early diagnosis of AD offers great opportunities for preventive treatment development in the near future.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s13760-017-0816-5

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 30 references

Cited by

See all 114

Metadata

Authors
Niemantsverdriet, E., Valckx, S., Bjerke, M., & Engelborghs, S.
Venue
Acta Neurologica Belgica
Published
2017-07-27
Volume
117
Issue
3
Pages
591-602
ISSN
  • 0300-9009 (ISSN-L)
  • 2240-2993
OpenAlex
W2739778633
Cited by
114
References
30
FWCI
8.37
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Alzheimer’s disease CSF biomarkers: clinical indications and rational use. https://app.cochat.ai/papers/10.1007/s13760-017-0816-5
The paper
Niemantsverdriet, E., Valckx, S., Bjerke, M., & Engelborghs, S. (2017). Alzheimer’s disease CSF biomarkers: clinical indications and rational use. Acta Neurologica Belgica. https://doi.org/10.1007/s13760-017-0816-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.